HistCite - The Kidney Transplant Papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
1993
1401	1401 MAKOWKA L, CHAPMAN F, CRAMER DV HISTORICAL DEVELOPMENT OF BREQUINAR SODIUM AS A NEW IMMUNOSUPPRESSIVE DRUG FOR TRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1993 JUN; 25 (3): 2-7	1	18	1	12
1402	1402 MOUTABARRIK A, TAKAHARA S, KOKADO Y, KAMEOKA H, TAKANO Y, et al. USE OF FK-506 IN KIDNEY-TRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1993 JUN; 25 (3): 2250-2252	2	2	1	3
1403	1403 TAKAYA S, BRONSTHER O, ABUELMAGD K, RAMOS H, FUNG JJ, et al. USE OF PROSTAGLANDIN-E1 IN CROSS-MATCH-NEGATIVE LIVER-TRANSPLANT RECIPIENTS TREATED WITH FK-506 TRANSPLANTATION PROCEEDINGS. 1993 JUN; 25 (3): 2381-2385	1	9	6	21
1404	1404 MOCHIZUKI M, MASUDA K, SAKANE T, ITO K, KOGURE M, et al. A CLINICAL-TRIAL OF FK506 IN REFRACTORY UVEITIS AMERICAN JOURNAL OF OPHTHALMOLOGY. 1993 JUN 15; 115 (6): 763-769	7	66	4	15
1405	1405 CHOU D THERAPEUTIC DRUG-MONITORING (IMMUNOSUPPRESSIVE DRUGS) ANALYTICAL CHEMISTRY. 1993 JUN 15; 65 (12): R412-R415	2	5	4	53
1406	1406 KINO T, GOTO T DISCOVERY OF FK-506 AND UPDATE ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 1993 JUN 23; 685: 13-21	5	23	8	50
1407	1407 STARZL TE, MURASE N, DEMETRIS AJ, ILDSTAD S, RICORDI C, et al. ALLOGRAFT AND XENOGRAFT ACCEPTANCE UNDER FK-506 AND OTHER IMMUNOSUPPRESSANT TREATMENT ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 1993 JUN 23; 685: 46-51	5	14	4	18
1408	1408 LANGER A, VALDIVIA LA, MURASE N, WOO J, CELLI S, et al. HUMORAL AND CELLULAR IMMUNOPATHOLOGY OF HEPATIC AND CARDIAC HAMSTER- INTO-RAT XENOGRAFT REJECTION - MARKED STIMULATION OF IGM++BRIGHT/IGD+DULL SPLENIC B-CELLS AMERICAN JOURNAL OF PATHOLOGY. 1993 JUL; 143 (1): 85-98	2	33	5	49
1409	1409 CETINKALE O, CIZMECI O, AYAN F, SENYUVA C, PUSANE A THE USE OF FK506 AND SKIN ALLOGRAFTING FOR THE TREATMENT OF SEVERE BURNS IN AN ANIMAL-MODEL BRITISH JOURNAL OF PLASTIC SURGERY. 1993 JUL; 46 (5): 410-415	1	7	4	33
1410	1410 KOCOSHIS SA, Tzakis AG, TODO S, REYES J, NOUR B PEDIATRIC LIVER-TRANSPLANTATION - HISTORY, RECENT INNOVATIONS, AND OUTLOOK FOR THE FUTURE CLINICAL PEDIATRICS. 1993 JUL; 32 (7): 386-392	0	10	11	59
#	Date / Author / Journal	LCS	GCS	LCR	CR
1411	1411 MCMICHAEL J, LIEBERMAN R, DOYLE H, MCCAULEY J, Fung JJ, et al. AN INTELLIGENT AND COST-EFFECTIVE COMPUTER DOSING SYSTEM FOR INDIVIDUALIZING FK506 THERAPY IN TRANSPLANTATION AND AUTOIMMUNE DISORDERS JOURNAL OF CLINICAL PHARMACOLOGY. 1993 JUL; 33 (7): 599-605	1	8	3	20
1412	1412 JAIN AB, ABUELMAGD K, ABDALLAH H, WARTY V, Fung JJ, et al. PHARMACOKINETICS OF FK506 IN LIVER-TRANSPLANT RECIPIENTS AFTER CONTINUOUS INTRAVENOUS-INFUSION JOURNAL OF CLINICAL PHARMACOLOGY. 1993 JUL; 33 (7): 606-611	11	41	8	17
1413	1413 WENZELSEIFERT K, SEIFERT R PARTIAL INHIBITION OF HUMAN NEUTROPHIL ACTIVATION BY FK-506 AT SUPRATHERAPEUTIC CONCENTRATIONS NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. 1993 JUL; 348 (1): 7-13	2	10	7	45
1414	1414 ROELEN DL, VANBREE FPMJ, SCHANZ U, VANROOD JJ, CLAAS FHJ DIFFERENTIAL INHIBITION OF PRIMED ALLOREACTIVE CTLS IN-VITRO BY CLINICALLY USED CONCENTRATIONS OF CYCLOSPORINE AND FK506 TRANSPLANTATION. 1993 JUL; 56 (1): 190-195	3	16	6	48
1415	1415 KNOOP C, ANDRIEN M, ANTOINE M, LAMBERMONT M, YERNAULT JC, et al. SEVERE HEMOLYSIS DUE TO A DONOR ANTI-D ANTIBODY AFTER HEART-LUNG TRANSPLANTATION - ASSOCIATION WITH LUNG AND BLOOD CHIMERISM AMERICAN REVIEW OF RESPIRATORY DISEASE. 1993 AUG; 148 (2): 504-506	3	23	1	18
1416	1416 KAHN D, GAVALER JS, MAKOWKA L, VANTHIEL DH GENDER OF DONOR INFLUENCES OUTCOME AFTER ORTHOTOPIC LIVER-TRANSPLANTATION IN ADULTS DIGESTIVE DISEASES AND SCIENCES. 1993 AUG; 38 (8): 1485-1488	0	36	2	21
1417	1417 MEISER B, REICHART B GRAFT VESSEL DISEASE - THE IMPACT OF IMMUNOSUPPRESSION AND POSSIBLE TREATMENT STRATEGIES IMMUNOLOGICAL REVIEWS. 1993 AUG; 134: 99-116	0	12	3	75
1418	1418 Tzakis AG, TODO S, REYES J, NOUR B, ABUELMAGD K, et al. INTESTINAL TRANSPLANTATION IN CHILDREN UNDER FK-506 IMMUNOSUPPRESSION JOURNAL OF PEDIATRIC SURGERY. 1993 AUG; 28 (8): 1040-1043	5	30	3	15
1419	1419 JACOBSSON J, SUNDBERG R, VALDIVIA LA, STARZL TE LIVER PRESERVATION WITH LIDOFLAZINE AND THE UNIVERSITY-OF-WISCONSIN SOLUTION - A DOSE-FINDING STUDY TRANSPLANTATION. 1993 AUG; 56 (2): 472-475	0	5	1	16
1420	1420 SHAEFER MS, COLLIER DS, HAVEN MC, LANGNAS AN, STRATTA RJ, et al. FALSELY ELEVATED FK-506 LEVELS CAUSED BY SAMPLING THROUGH CENTRAL VENOUS CATHETERS TRANSPLANTATION. 1993 AUG; 56 (2): 475-476	3	5	4	17
#	Date / Author / Journal	LCS	GCS	LCR	CR
1421	1421 VALDIVIA LA, DEMETRIS AJ, LANGER AM, CELLI S, FUNG JJ, et al. DENDRITIC CELL REPLACEMENT IN LONG-SURVIVING LIVER AND CARDIAC XENOGRAFTS TRANSPLANTATION. 1993 AUG; 56 (2): 482-484	4	7	1	7
1422	1422 KAHAN BD TIMELINE OF IMMUNOSUPPRESSION TRANSPLANTATION PROCEEDINGS. 1993 AUG; 25 (4): 1-4	0	2	4	69
1423	1423 STARZL TE, DEMETRIS AJ, TRUCCO M MATCHING AND THE BLACK RECIPIENT TRANSPLANTATION PROCEEDINGS. 1993 AUG; 25 (4): 2450-2451	1	4	6	14
1424	1424 TOUSSAINT RM, MEZGHEBE HH, MILLIS RM HEPATIC TRANSPLANTATION IN THE UNITED-STATES TRANSPLANTATION PROCEEDINGS. 1993 AUG; 25 (4): 2481-2483	0	0	4	32
1425	1425 RAPAPORT FT CONTINUING DILEMMA OF ORGAN PROCUREMENT FOR CLINICAL TRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1993 AUG; 25 (4): 2494-2495	0	1	2	8
1426	1426 MCMASTER P, BUIST L FK-506 IN TRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1993 AUG; 25 (4): 2684-2685	4	10	2	6
1427	1427 JOST U, WINKLER M, RINGE B, RODECK B, PICHLMAYR R FK-506 TREATMENT OF INTRACTABLE REJECTION AFTER LIVER-TRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1993 AUG; 25 (4): 2686-2687	4	4	1	3
1428	1428 WINKLER M, RINGE B, JOST U, GUBERNATIS G, PICHLMAYR R PLASMA LEVEL-GUIDED LOW-DOSE FK-506 THERAPY IN PATIENTS WITH EARLY LIVER DYSFUNCTION AFTER LIVER- TRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1993 AUG; 25 (4): 2688-2690	6	8	5	7
1429	1429 WHITE DJG IMMUNOSUPPRESSION FOR HEART-TRANSPLANTATION BRITISH JOURNAL OF BIOMEDICAL SCIENCE. 1993 SEP; 50 (3): 277-283	0	4	2	31
1430	1430 LYSON T, ERMEL LD, BELSHAW PJ, ALBERG DG, SCHREIBER SL, et al. CYCLOSPORINE-INDUCED AND FK506-INDUCED SYMPATHETIC ACTIVATION CORRELATES WITH CALCINEURIN-MEDIATED INHIBITION OF T-CELL SIGNALING CIRCULATION RESEARCH. 1993 SEP; 73 (3): 596-602	4	64	5	44
#	Date / Author / Journal	LCS	GCS	LCR	CR
1431	1431 GONZALEZ AL, CONDE C, REVILLA C, RAMOS A, RENEDO B, et al. AUTOIMMUNE SYNDROME AFTER INDUCTION OF NEONATAL TOLERANCE TO I-E ANTIGENS EUROPEAN JOURNAL OF IMMUNOLOGY. 1993 SEP; 23 (9): 2353-2357	0	11	1	36
1432	1432 STARZL TE THE EMERGENCE OF LIVER-TRANSPLANTATION - A CITATION-CLASSIC COMMENTARY ON EVOLUTION OF LIVER-TRANSPLANTATION BY STARZL,T.E., IWATSUKI,S., VANTHIEL,D.H., GARTNER,J.C., ZITELLI,B.J., MALATACK,J.J., SCHADE,R.R., SHAW,B.W., HAKALA,T.R., ROSENTHAL,J.T., AND PORTER,K.A. CURRENT CONTENTS/CLINICAL MEDICINE. 1993 SEP 6; (36): 8-8	0	0	5	9
1433	1433 PETERS DH, FITTON A, PLOSKER GL, FAULDS D TACROLIMUS - A REVIEW OF ITS PHARMACOLOGY, AND THERAPEUTIC POTENTIAL IN HEPATIC AND RENAL-TRANSPLANTATION DRUGS. 1993 OCT; 46 (4): 746-794	28	238	78	328
1434	1434 WOOD KJ PERIPHERAL TOLERANCE TO ALLOANTIGEN - STRATEGIES FOR THE FUTURE EUROPEAN JOURNAL OF IMMUNOGENETICS. 1993 OCT; 20 (5): 439-449	0	2	1	69
1435	1435 STARZL TE FRANCE AND THE EARLY HISTORY OF ORGAN-TRANSPLANTATION PERSPECTIVES IN BIOLOGY AND MEDICINE. 1993 FAL; 37 (1): 35-47	0	0	10	66
1436	1436 ABUELMAGD KM, MALINCHOC M, DICKSON ER, FUNG JJ, MURTAUGH PA, et al. EFFICACY OF HEPATIC TRANSPLANTATION IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS SURGERY GYNECOLOGY & OBSTETRICS. 1993 OCT; 177 (4): 335-344	2	72	1	40
1437	1437 MCDIARMID SV, COLONNA JO, SHAKED A, AMENT ME, BUSUTTIL RW A COMPARISON OF RENAL-FUNCTION IN CYCLOSPORINE-TREATED AND FK-506-TREATED PATIENTS AFTER PRIMARY ORTHOTOPIC LIVER-TRANSPLANTATION TRANSPLANTATION. 1993 OCT; 56 (4): 847-853	14	73	15	50
1438	1438 TABASCOMINGUILLAN J, MIELES L, CARROLL P, GAVALER J, VANTHIEL DH, et al. INSULIN REQUIREMENTS AFTER LIVER-TRANSPLANTATION AND FK-506 IMMUNOSUPPRESSION TRANSPLANTATION. 1993 OCT; 56 (4): 862-867	6	37	10	24
1439	1439 WREN SM, WANG SC, THAI NL, CONRAD B, HOFFMAN RA, et al. EVIDENCE FOR EARLY TH2 T-CELL PREDOMINANCE IN XENOREACTIVITY TRANSPLANTATION. 1993 OCT; 56 (4): 905-911	1	41	2	43
1440	1440 SCHLITT HJ, KANEHIRO H, RADDATZ G, STEINHOFF G, RICHTER N, et al. PERSISTENCE OF DONOR LYMPHOCYTES IN LIVER ALLOGRAFT RECIPIENTS TRANSPLANTATION. 1993 OCT; 56 (4): 1001-1007	48	97	2	36
#	Date / Author / Journal	LCS	GCS	LCR	CR
1441	1441 KAMADA N, GOTO S, KOBAYASHI E, ENOSAWA S, DELRIVIERE L, et al. RELEASE OF SOLUBLE MHC CLASS-I ANTIGENS BEFORE AND AFTER ORTHOTOPIC LIVER RETRANSPLANTATION IN THE RAT TRANSPLANTATION PROCEEDINGS. 1993 OCT; 25 (5): 2857-2857	3	5	1	4
1442	1442 KAMADA N, KOBAYASHI E, DELRIVIERE L, GOTO S, LORD R, et al. MIGRATION OF CELLS ENCODED BY DONOR-TYPE MHC CLASS-I ANTIGENS AFTER LIVER-TRANSPLANTATION IN THE RAT TRANSPLANTATION PROCEEDINGS. 1993 OCT; 25 (5): 2858-2858	3	4	1	5
1443	1443 BUTTEMEYER R, JONES NF, VOGT P, STEINAU HU CURRENT STATUS OF EXPERIMENTAL ALLOGENIC LIMB TRANSPLANTATION CHIRURG. 1993 NOV; 64 (11): 907-912	0	4	1	44
1444	1444 WALLEMACQ PE, REDING R FK506 (TACROLIMUS), A NOVEL IMMUNOSUPPRESSANT IN ORGAN-TRANSPLANTATION - CLINICAL, BIOMEDICAL, AND ANALYTICAL ASPECTS CLINICAL CHEMISTRY. 1993 NOV; 39 (11): 2219-2228	13	81	22	101
1445	1445 LEMSTER B, WOO J, THOMSON AW BLOOD-LYMPHOCYTES OF AUTOIMMUNE-DISEASE PATIENTS RECEIVING FK506 EXHIBIT NORMAL EX-VIVO CYTOKINE GENE- EXPRESSION AND PROLIFERATIVE RESPONSES IMMUNOLOGY LETTERS. 1993 NOV; 38 (3): 179-183	0	1	5	25
1446	1446 FABIAN MC, LAKEY JRT, RAJOTTE RV, KNETEMAN NM THE EFFICACY AND TOXICITY OF RAPAMYCIN IN MURINE ISLET TRANSPLANTATION - IN-VITRO AND IN-VIVO STUDIES TRANSPLANTATION. 1993 NOV; 56 (5): 1137-1142	2	46	6	45
1447	1447 WOODLE ES, PHELAN DL, SAFFITZ JE, MOHANAKUMAR T, SHENOY S, et al. FK506 - REVERSAL OF HUMORALLY MEDIATED CARDIAC ALLOGRAFT-REJECTION IN THE PRESENCE OF PREFORMED ANTICLASS-I ANTIBODY TRANSPLANTATION. 1993 NOV; 56 (5): 1271-1275	1	6	7	25
1448	1448 CLARK CLI, GROVER R, POCKLEY AG, WOOD RFM DELAYED-START CYCLOSPORINE IMMUNOSUPPRESSION REDUCES GRAFT CELL-MIGRATION AFTER SMALL-BOWEL TRANSPLANTATION TRANSPLANTATION. 1993 NOV; 56 (5): 1284-1286	0	3	1	15
1449	1449 LOPEZGIL JA, SAIZ MG FK506 - AN IMMUNOSUPPRESSOR FOR THE 90S MEDICINA CLINICA. 1993 NOV 13; 101 (16): 629-636	1	2	34	83
1450	1450 KODAMA M, HANAWA H, ZHANG S, SAEKI M, KOYAMA S, et al. FK506-THERAPY OF EXPERIMENTAL AUTOIMMUNE MYOCARDITIS AFTER ONSET OF THE DISEASE AMERICAN HEART JOURNAL. 1993 DEC; 126 (6): 1385-1392	0	21	3	48
#	Date / Author / Journal	LCS	GCS	LCR	CR
1451	1451 HEINEKE EW, JOHNSON MB, DILLBERGER JE, ROBINSON KM ANTIOXIDANT MDL 29,311 PREVENTS DIABETES IN NONOBESE DIABETIC AND MULTIPLE LOW-DOSE STZ-INJECTED MICE DIABETES. 1993 DEC; 42 (12): 1721-1730	0	18	3	70
1452	1452 KRENTZ AJ, DOUSSET B, MAYER D, MCMASTER P, BUCKELS J, et al. METABOLIC EFFECTS OF CYCLOSPORINE-A AND FK-506 IN LIVER-TRANSPLANT RECIPIENTS DIABETES. 1993 DEC; 42 (12): 1753-1759	10	78	5	32
1453	1453 THOMSON AW, STARZL TE NEW IMMUNOSUPPRESSIVE DRUGS - MECHANISTIC INSIGHTS AND POTENTIAL THERAPEUTIC ADVANCES IMMUNOLOGICAL REVIEWS. 1993 DEC; 136: 71-98	14	91	12	90
1454	1454 TUFVESON G, GANNEDAHL G, JOHNSSON C, OLAUSSON M, WANDERS A, et al. NEW IMMUNOSUPPRESSANTS - TESTING AND DEVELOPMENT IN ANIMAL-MODELS AND THE CLINIC - WITH SPECIAL REFERENCE TO DSG IMMUNOLOGICAL REVIEWS. 1993 DEC; 136: 99-109	1	16	4	34
1455	1455 LIEBERMAN R, NELSON R DOSE-RESPONSE AND CONCENTRATION RESPONSE RELATIONSHIPS - CLINICAL AND REGULATORY PERSPECTIVES THERAPEUTIC DRUG MONITORING. 1993 DEC; 15 (6): 498-502	0	8	1	11
1456	1456 MATSUURA T, HARA Y, IMANISHI M, KANDA H, KURITA T PROLONGED SURVIVAL OF RAT CARDIAC ALLOGRAFTS INDUCED BY INTRATHYMIC INJECTION OF DONOR BONE-MARROW CELLS TRANSPLANTATION PROCEEDINGS. 1993 DEC; 25 (6): 3283-3285	2	6	1	13
1457	1457 REYES J, ZEEVI A, RAMOS H, Tzakis AG, TODO S, et al. FREQUENT ACHIEVEMENT OF A DRUG-FREE STATE AFTER ORTHOTOPIC LIVER- TRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1993 DEC; 25 (6): 3315-3319	30	52	5	9
1458	1458 DEMETRIS AJ, MURASE N, FUJISAKI S, FUNG JJ, RAO AS, et al. HEMATOLYMPHOID CELL TRAFFICKING, MICROCHIMERISM, AND GVH REACTIONS AFTER LIVER, BONE-MARROW, AND HEART-TRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1993 DEC; 25 (6): 3337-3344	90	120	6	32
1459	1459 BUSCH MP, LEE TH, DONEGAN E, PALLAVICINI M USE OF AN INBRED MOUSE MODEL SYSTEM FOR STUDIES OF ALLOGENEIC TRANSFUSION-INDUCED IMMUNOSUPPRESSION BLOOD. 1993 DEC 1; 82 (11): 3509-3510	0	3	1	11
1994
1460	1460 Tzakis AG, TODO S, STARZL TE INTESTINAL TRANSPLANTATION ANNUAL REVIEW OF MEDICINE. 1994; 45: 79-91	2	15	6	21
#	Date / Author / Journal	LCS	GCS	LCR	CR
1461	1461 YOUNG W, KUMEKICK J, CONSTANTINI S GLUCOCORTICOID THERAPY OF SPINAL-CORD INJURY HORMONAL RESTRUCTURING OF THE ADULT BRAIN. 1994; 743: 241-265	0	20	3	245
1462	1462 WILLIAMS LA, EGNER W, HART DNJ ISOLATION AND FUNCTION OF HUMAN DENDRITIC CELLS INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 153. 1994; 153: 41-103	1	57	1	228
1463	1463 LEE RS, AUCHINCLOSS H MECHANISMS OF TOLERANCE TO ALLOGRAFTS MECHANISMS OF IMMUNE REGULATION. 1994; 58: 236-258	0	1	2	199
1464	1464 MOCHIZUKI M, DESMET M USE OF IMMUNOSUPPRESSIVE AGENTS IN OCULAR DISEASES PROGRESS IN RETINAL AND EYE RESEARCH. 1994; 13 (2): 479-506	0	11	16	153
1465	1465 MATSUNAMI H, TADA A, MAKUUCHI M, LYNCH SV, STRONG RW NEW TECHNIQUE FOR MEASURING TACROLIMUS CONCENTRATIONS IN BLOOD AMERICAN JOURNAL OF HOSPITAL PHARMACY. 1994 JAN; 51 (1): 123-123	1	1	3	4
1466	1466 GORCZYNSKI RM ADOPTIVE TRANSFER OF UNRESPONSIVENESS TO ALLOGENEIC SKIN-GRAFTS WITH HEPATIC GAMMA-DELTA(+) T-CELLS IMMUNOLOGY. 1994 JAN; 81 (1): 27-35	5	63	1	25
1467	1467 DUNCAN JI DIFFERENTIAL INHIBITION OF CUTANEOUS T-CELL-MEDIATED REACTIONS AND EPIDERMAL-CELL PROLIFERATION BY CYCLOSPORINE-A, FK-506, AND RAPAMYCIN JOURNAL OF INVESTIGATIVE DERMATOLOGY. 1994 JAN; 102 (1): 84-88	1	46	5	38
1468	1468 DUMONT FJ, KASTNER C, IACOVONE F, FISCHER PA QUANTITATIVE AND TEMPORAL ANALYSIS OF THE CELLULAR INTERACTION OF FK-506 AND RAPAMYCIN IN T-LYMPHOCYTES JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 1994 JAN; 268 (1): 32-41	2	30	5	48
1469	1469 JINDAL RM, TEPPER MA, SOLTYS K, CHO SI DEOXYSPERGUALIN - A NOVEL IMMUNOSUPPRESSANT MOUNT SINAI JOURNAL OF MEDICINE. 1994 JAN; 61 (1): 51-56	2	6	1	51
1470	1470 REDING R, WALLEMACQ PE, LAMY ME, RAHIER J, SEMPOUX C, et al. CONVERSION FROM CYCLOSPORINE TO FK506 FOR SALVAGE OF IMMUNOCOMPROMISED PEDIATRIC LIVER ALLOGRAFTS - EFFICACY, TOXICITY, AND DOSE REGIMEN IN 23 CHILDREN TRANSPLANTATION. 1994 JAN; 57 (1): 93-100	16	63	4	23
#	Date / Author / Journal	LCS	GCS	LCR	CR
1471	1471 MANEZ R, KUSNE S, LINDEN P, GONZALEZPINTO I, BONET H, et al. TEMPORARY WITHDRAWAL, OF IMMUNOSUPPRESSION FOR LIFE-THREATENING INFECTIONS AFTER LIVER-TRANSPLANTATION TRANSPLANTATION. 1994 JAN; 57 (1): 149-151	7	18	5	11
1472	1472 CANTAROVICH D, LEMAUFF B, HOURMANT M, DANTAL J, BAATARD R, et al. PREVENTION OF ACUTE REJECTION EPISODES WITH AN ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL-ANTIBODY .1. RESULTS AFTER COMBINED PANCREAS AND KIDNEY-TRANSPLANTATION TRANSPLANTATION. 1994 JAN; 57 (2): 198-203	1	26	1	24
1473	1473 RUBOCKI RJ, LANGNAS AN, SHEPHERD S, DEGENHARDT JA, CATTRAL MS, et al. THE ORIGIN OF LYMPHOCYTES IN DONOR-DERIVED LYMPH-NODES FOLLOWING COMBINED LIVER AND SMALL-BOWEL TRANSPLANTATION TRANSPLANTATION. 1994 JAN; 57 (2): 303-306	3	4	2	14
1474	1474 CALNE R, DAVIES H ORGAN GRAFT TOLERANCE - THE LIVER EFFECT LANCET. 1994 JAN 8; 343 (8889): 67-68	27	63	4	12
1475	1475 BRONSTHER O, FUNG JJ, IZAKIS A, VanThiel DH, STARZL TE PRIORITIZATION AND ORGAN DISTRIBUTION FOR LIVER-TRANSPLANTATION JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 1994 JAN 12; 271 (2): 140-143	2	37	4	15
1476	1476 ROLLES K, BURROUGHS AK, DAVIDSON BR, KARATAPANIS S, PRENTICE HG, et al. DONOR-SPECIFIC BONE-MARROW INFUSION AFTER ORTHOTOPIC LIVER-TRANSPLANTATION LANCET. 1994 JAN 29; 343 (8892): 263-265	28	54	1	5
1477	1477 CARTON EG, PLEVAK DJ, KRANNER PW, RETTKE SR, GEIGER HJ, et al. PERIOPERATIVE CARE OF THE LIVER-TRANSPLANT PATIENT .2. ANESTHESIA AND ANALGESIA. 1994 FEB; 78 (2): 382-399	1	51	3	151
1478	1478 YAMAMOTO S, JIANG H, KATO R STIMULATION OF HAIR-GROWTH BY TOPICAL APPLICATION OF FK506, A POTENT IMMUNOSUPPRESSIVE AGENT JOURNAL OF INVESTIGATIVE DERMATOLOGY. 1994 FEB; 102 (2): 160-164	5	42	6	30
1479	1479 MARTIN MF NEPHROTOXIC EFFECTS OF IMMUNOSUPPRESSION MAYO CLINIC PROCEEDINGS. 1994 FEB; 69 (2): 191-192	1	5	7	14
1480	1480 COOPER MH, GREGORY SH, STARZL TE, WING EJ RAPAMYCIN BUT NOT FK506 INHIBITS THE PROLIFERATION OF MONONUCLEAR PHAGOCYTES INDUCED BY COLONY-STIMULATING FACTORS TRANSPLANTATION. 1994 FEB 15; 57 (3): 433-439	0	17	11	40
#	Date / Author / Journal	LCS	GCS	LCR	CR
1481	1481 ANDOH TF, BURDMANN EA, LINDSLEY J, HOUGHTON DC, BENNETT WM ENHANCEMENT OF FK506 NEPHROTOXICITY BY SODIUM DEPLETION IN AN EXPERIMENTAL RAT MODEL TRANSPLANTATION. 1994 FEB 27; 57 (4): 483-489	11	40	17	52
1482	1482 BACKMAN L, NICAR M, LEVY M, DISTANT D, EISENSTEIN C, et al. FK506 TROUGH LEVELS IN WHOLE-BLOOD AND PLASMA IN LIVER-TRANSPLANT RECIPIENTS - CORRELATION WITH CLINICAL EVENTS AND SIDE-EFFECTS TRANSPLANTATION. 1994 FEB 27; 57 (4): 519-525	16	80	4	29
1483	1483 NIKAEIN A, COLLINS RH, KLINTMALM G, POOLE T, FAY JW, et al. IMMUNOLOGICAL MONITORING OF GRAFT-VERSUS-HOST DISEASE FOLLOWING ORTHOTOPIC LIVER-TRANSPLANTATION TRANSPLANTATION. 1994 FEB 27; 57 (4): 637-640	3	6	2	15
1484	1484 LEE MS, WOGENSEN L, SHIZURU J, OLDSTONE MBA, SARVETNICK N PANCREATIC-ISLET PRODUCTION OF MURINE INTERLEUKIN-10 DOES NOT INHIBIT IMMUNE-MEDIATED TISSUE DESTRUCTION JOURNAL OF CLINICAL INVESTIGATION. 1994 MAR; 93 (3): 1332-1338	1	110	1	29
1485	1485 CHARPENTIER B, ALARD P, HIESSE C, LANTZ O INDUCTION OF PERIPHERAL T-CELL TOLERANCE AND ALLO/XENOIMMUNITY PATHOLOGIE BIOLOGIE. 1994 MAR; 42 (3): 237-240	0	0	1	21
1486	1486 RYDER SD, WILLIAMS R LIVER-DISEASE POSTGRADUATE MEDICAL JOURNAL. 1994 MAR; 70 (821): 162-184	0	2	5	267
1487	1487 BENDAHAN J, TYLER M, LOTZ Z, MCLEOD H, ENGELBRECHT GHC, et al. THE EFFECT OF ADMINISTRATION OF FK506 ON DELAYED REGENERATION IN FLUSHED PARTIALLY HEPATECTOMIZED LIVERS TRANSPLANTATION. 1994 MAR 15; 57 (5): 655-658	1	3	4	18
1488	1488 HIGH KP, JOINER KA, HANDSCHUMACHER RE ISOLATION, CDNA SEQUENCES, AND BIOCHEMICAL-CHARACTERIZATION OF THE MAJOR CYCLOSPORINE-BINDING PROTEINS OF TOXOPLASMA-GONDII JOURNAL OF BIOLOGICAL CHEMISTRY. 1994 MAR 25; 269 (12): 9105-9112	0	46	3	69
1489	1489 SHARMA UK, JHA V, GUPTA KL, JOSHI K, SAKHUJA V DE-NOVO DIABETIC GLOMERULOSCLEROSIS IN A RENAL-ALLOGRAFT RECIPIENT AMERICAN JOURNAL OF KIDNEY DISEASES. 1994 APR; 23 (4): 597-599	0	6	4	14
1490	1490 WIJDICKS EFM, WIESNER RH, DAHLKE LJ, KROM RAF FK506-INDUCED NEUROTOXICITY IN LIVER-TRANSPLANTATION ANNALS OF NEUROLOGY. 1994 APR; 35 (4): 498-501	5	79	3	9
#	Date / Author / Journal	LCS	GCS	LCR	CR
1491	1491 HOOKS MA TACROLIMUS, A NEW IMMUNOSUPPRESSANT - A REVIEW OF THE LITERATURE ANNALS OF PHARMACOTHERAPY. 1994 APR; 28 (4): 501-511	5	64	24	85
1492	1492 QIAN SW, DEMETRIS AJ, MURASE N, RAO AS, FUNG JJ, et al. MURINE LIVER ALLOGRAFT TRANSPLANTATION - TOLERANCE AND DONOR CELL CHIMERISM HEPATOLOGY. 1994 APR; 19 (4): 916-924	135	280	6	45
1493	1493 SANDBORN WJ, HAY JE, PORAYKO MK, GORES GJ, STEERS JL, et al. CYCLOSPORINE WITHDRAWAL FOR NEPHROTOXICITY IN LIVER-TRANSPLANT RECIPIENTS DOES NOT RESULT IN SUSTAINED IMPROVEMENT IN KIDNEY-FUNCTION AND CAUSES CELLULAR AND DUCTOPENIC REJECTION HEPATOLOGY. 1994 APR; 19 (4): 925-932	18	68	8	43
1494	1494 KUBIT V, SONMEZALPAN E, ZEEVI A, PARADIS I, DAUBER JH, et al. MIXED ALLOGENEIC CHIMERISM IN LUNG ALLOGRAFT RECIPIENTS HUMAN PATHOLOGY. 1994 APR; 25 (4): 408-412	13	22	5	26
1495	1495 WIGHT DGD ASPECTS OF LIVER-TRANSPLANT PATHOLOGY WITH EMPHASIS ON REJECTION AND ITS MECHANISMS JOURNAL OF CLINICAL PATHOLOGY. 1994 APR; 47 (4): 296-299	0	2	9	73
1496	1496 STRATTA RJ, TAYLOR RJ, BYNON JS, LOWELL JA, FRISBIE K, et al. PATTERNS OF REJECTION AFTER COMBINED PANCREAS-KIDNEY TRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1994 APR; 26 (2): 524-525	0	10	1	24
1497	1497 CVETKOVIC M, MANN GN, ROMERO DF, LIANG XG, MA YF, et al. THE DELETERIOUS EFFECTS OF LONG-TERM CYCLOSPORINE-A, CYCLOSPORINE-G, AND FK506 ON BONE-MINERAL METABOLISM IN-VIVO TRANSPLANTATION. 1994 APR 27; 57 (8): 1231-1237	0	174	4	47
1498	1498 CATTRAL MS, LANGNAS AN, WISECARVER JL, HARPER JC, RUBOCKI RJ, et al. SURVIVAL OF GRAFT-VERSUS-HOST DISEASE IN A LIVER-TRANSPLANT RECIPIENT TRANSPLANTATION. 1994 APR 27; 57 (8): 1271-1274	7	26	2	28
1499	1499 BUSUTTIL RW, SHAKED A, MILLIS JM, JURIM O, COLQUHOUN SD, et al. 1,000 LIVER-TRANSPLANTS - THE LESSONS LEARNED ANNALS OF SURGERY. 1994 MAY; 219 (5): 490-499	4	102	4	38
1500	1500 [Anon] BASIC AND CLINICAL CONSIDERATIONS IN THE USE OF XENOGRAFTS CURRENT PROBLEMS IN SURGERY. 1994 MAY; 31 (5): 396-460	0	0	11	236

Date / Author / Journal

LCS

GCS

LCR

1993

1401

1401 MAKOWKA L, CHAPMAN F, CRAMER DV

HISTORICAL DEVELOPMENT OF BREQUINAR SODIUM AS A NEW IMMUNOSUPPRESSIVE DRUG FOR TRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1993 JUN; 25 (3): 2-7

1402

1402 MOUTABARRIK A, TAKAHARA S, KOKADO Y, KAMEOKA H, TAKANO Y, et al.

USE OF FK-506 IN KIDNEY-TRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1993 JUN; 25 (3): 2250-2252

1403

1403 TAKAYA S, BRONSTHER O, ABUELMAGD K, RAMOS H, FUNG JJ, et al.

USE OF PROSTAGLANDIN-E1 IN CROSS-MATCH-NEGATIVE LIVER-TRANSPLANT RECIPIENTS TREATED WITH FK-506

TRANSPLANTATION PROCEEDINGS. 1993 JUN; 25 (3): 2381-2385

1404

1404 MOCHIZUKI M, MASUDA K, SAKANE T, ITO K, KOGURE M, et al.

A CLINICAL-TRIAL OF FK506 IN REFRACTORY UVEITIS

AMERICAN JOURNAL OF OPHTHALMOLOGY. 1993 JUN 15; 115 (6): 763-769

1405

1405 CHOU D

THERAPEUTIC DRUG-MONITORING (IMMUNOSUPPRESSIVE DRUGS)

ANALYTICAL CHEMISTRY. 1993 JUN 15; 65 (12): R412-R415

1406

1406 KINO T, GOTO T

DISCOVERY OF FK-506 AND UPDATE

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 1993 JUN 23; 685: 13-21

1407

1407 STARZL TE, MURASE N, DEMETRIS AJ, ILDSTAD S, RICORDI C, et al.

ALLOGRAFT AND XENOGRAFT ACCEPTANCE UNDER FK-506 AND OTHER IMMUNOSUPPRESSANT TREATMENT

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 1993 JUN 23; 685: 46-51

1408

1408 LANGER A, VALDIVIA LA, MURASE N, WOO J, CELLI S, et al.

HUMORAL AND CELLULAR IMMUNOPATHOLOGY OF HEPATIC AND CARDIAC HAMSTER- INTO-RAT XENOGRAFT REJECTION - MARKED STIMULATION OF IGM++BRIGHT/IGD+DULL SPLENIC B-CELLS

AMERICAN JOURNAL OF PATHOLOGY. 1993 JUL; 143 (1): 85-98

1409

1409 CETINKALE O, CIZMECI O, AYAN F, SENYUVA C, PUSANE A

THE USE OF FK506 AND SKIN ALLOGRAFTING FOR THE TREATMENT OF SEVERE BURNS IN AN ANIMAL-MODEL

BRITISH JOURNAL OF PLASTIC SURGERY. 1993 JUL; 46 (5): 410-415

1410

1410 KOCOSHIS SA, Tzakis AG, TODO S, REYES J, NOUR B

PEDIATRIC LIVER-TRANSPLANTATION - HISTORY, RECENT INNOVATIONS, AND OUTLOOK FOR THE FUTURE

CLINICAL PEDIATRICS. 1993 JUL; 32 (7): 386-392

Date / Author / Journal

LCS

GCS

LCR

1411

1411 MCMICHAEL J, LIEBERMAN R, DOYLE H, MCCAULEY J, Fung JJ, et al.

AN INTELLIGENT AND COST-EFFECTIVE COMPUTER DOSING SYSTEM FOR INDIVIDUALIZING FK506 THERAPY IN TRANSPLANTATION AND AUTOIMMUNE DISORDERS

JOURNAL OF CLINICAL PHARMACOLOGY. 1993 JUL; 33 (7): 599-605

1412

1412 JAIN AB, ABUELMAGD K, ABDALLAH H, WARTY V, Fung JJ, et al.

PHARMACOKINETICS OF FK506 IN LIVER-TRANSPLANT RECIPIENTS AFTER CONTINUOUS INTRAVENOUS-INFUSION

JOURNAL OF CLINICAL PHARMACOLOGY. 1993 JUL; 33 (7): 606-611

1413

1413 WENZELSEIFERT K, SEIFERT R

PARTIAL INHIBITION OF HUMAN NEUTROPHIL ACTIVATION BY FK-506 AT SUPRATHERAPEUTIC CONCENTRATIONS

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. 1993 JUL; 348 (1): 7-13

1414

1414 ROELEN DL, VANBREE FPMJ, SCHANZ U, VANROOD JJ, CLAAS FHJ

DIFFERENTIAL INHIBITION OF PRIMED ALLOREACTIVE CTLS IN-VITRO BY CLINICALLY USED CONCENTRATIONS OF CYCLOSPORINE AND FK506

TRANSPLANTATION. 1993 JUL; 56 (1): 190-195

1415

1415 KNOOP C, ANDRIEN M, ANTOINE M, LAMBERMONT M, YERNAULT JC, et al.

SEVERE HEMOLYSIS DUE TO A DONOR ANTI-D ANTIBODY AFTER HEART-LUNG TRANSPLANTATION - ASSOCIATION WITH LUNG AND BLOOD CHIMERISM

AMERICAN REVIEW OF RESPIRATORY DISEASE. 1993 AUG; 148 (2): 504-506

1416

1416 KAHN D, GAVALER JS, MAKOWKA L, VANTHIEL DH

GENDER OF DONOR INFLUENCES OUTCOME AFTER ORTHOTOPIC LIVER-TRANSPLANTATION IN ADULTS

DIGESTIVE DISEASES AND SCIENCES. 1993 AUG; 38 (8): 1485-1488

1417

1417 MEISER B, REICHART B

GRAFT VESSEL DISEASE - THE IMPACT OF IMMUNOSUPPRESSION AND POSSIBLE TREATMENT STRATEGIES

IMMUNOLOGICAL REVIEWS. 1993 AUG; 134: 99-116

1418

1418 Tzakis AG, TODO S, REYES J, NOUR B, ABUELMAGD K, et al.

INTESTINAL TRANSPLANTATION IN CHILDREN UNDER FK-506 IMMUNOSUPPRESSION

JOURNAL OF PEDIATRIC SURGERY. 1993 AUG; 28 (8): 1040-1043

1419

1419 JACOBSSON J, SUNDBERG R, VALDIVIA LA, STARZL TE

LIVER PRESERVATION WITH LIDOFLAZINE AND THE UNIVERSITY-OF-WISCONSIN SOLUTION - A DOSE-FINDING STUDY

TRANSPLANTATION. 1993 AUG; 56 (2): 472-475

1420

1420 SHAEFER MS, COLLIER DS, HAVEN MC, LANGNAS AN, STRATTA RJ, et al.

FALSELY ELEVATED FK-506 LEVELS CAUSED BY SAMPLING THROUGH CENTRAL VENOUS CATHETERS

TRANSPLANTATION. 1993 AUG; 56 (2): 475-476

Date / Author / Journal

LCS

GCS

LCR

1421

1421 VALDIVIA LA, DEMETRIS AJ, LANGER AM, CELLI S, FUNG JJ, et al.

DENDRITIC CELL REPLACEMENT IN LONG-SURVIVING LIVER AND CARDIAC XENOGRAFTS

TRANSPLANTATION. 1993 AUG; 56 (2): 482-484

1422

1422 KAHAN BD

TIMELINE OF IMMUNOSUPPRESSION

TRANSPLANTATION PROCEEDINGS. 1993 AUG; 25 (4): 1-4

1423

1423 STARZL TE, DEMETRIS AJ, TRUCCO M

MATCHING AND THE BLACK RECIPIENT

TRANSPLANTATION PROCEEDINGS. 1993 AUG; 25 (4): 2450-2451

1424

1424 TOUSSAINT RM, MEZGHEBE HH, MILLIS RM

HEPATIC TRANSPLANTATION IN THE UNITED-STATES

TRANSPLANTATION PROCEEDINGS. 1993 AUG; 25 (4): 2481-2483

1425

1425 RAPAPORT FT

CONTINUING DILEMMA OF ORGAN PROCUREMENT FOR CLINICAL TRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1993 AUG; 25 (4): 2494-2495

1426

1426 MCMASTER P, BUIST L

FK-506 IN TRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1993 AUG; 25 (4): 2684-2685

1427

1427 JOST U, WINKLER M, RINGE B, RODECK B, PICHLMAYR R

FK-506 TREATMENT OF INTRACTABLE REJECTION AFTER LIVER-TRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1993 AUG; 25 (4): 2686-2687

1428

1428 WINKLER M, RINGE B, JOST U, GUBERNATIS G, PICHLMAYR R

PLASMA LEVEL-GUIDED LOW-DOSE FK-506 THERAPY IN PATIENTS WITH EARLY LIVER DYSFUNCTION AFTER LIVER- TRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1993 AUG; 25 (4): 2688-2690

1429

1429 WHITE DJG

IMMUNOSUPPRESSION FOR HEART-TRANSPLANTATION

BRITISH JOURNAL OF BIOMEDICAL SCIENCE. 1993 SEP; 50 (3): 277-283

1430

1430 LYSON T, ERMEL LD, BELSHAW PJ, ALBERG DG, SCHREIBER SL, et al.

CYCLOSPORINE-INDUCED AND FK506-INDUCED SYMPATHETIC ACTIVATION CORRELATES WITH CALCINEURIN-MEDIATED INHIBITION OF T-CELL SIGNALING

CIRCULATION RESEARCH. 1993 SEP; 73 (3): 596-602

Date / Author / Journal

LCS

GCS

LCR

1431

1431 GONZALEZ AL, CONDE C, REVILLA C, RAMOS A, RENEDO B, et al.

AUTOIMMUNE SYNDROME AFTER INDUCTION OF NEONATAL TOLERANCE TO I-E ANTIGENS

EUROPEAN JOURNAL OF IMMUNOLOGY. 1993 SEP; 23 (9): 2353-2357

1432

1432 STARZL TE

THE EMERGENCE OF LIVER-TRANSPLANTATION - A CITATION-CLASSIC COMMENTARY ON EVOLUTION OF LIVER-TRANSPLANTATION BY STARZL,T.E., IWATSUKI,S., VANTHIEL,D.H., GARTNER,J.C., ZITELLI,B.J., MALATACK,J.J., SCHADE,R.R., SHAW,B.W., HAKALA,T.R., ROSENTHAL,J.T., AND PORTER,K.A.

CURRENT CONTENTS/CLINICAL MEDICINE. 1993 SEP 6; (36): 8-8

1433

1433 PETERS DH, FITTON A, PLOSKER GL, FAULDS D

TACROLIMUS - A REVIEW OF ITS PHARMACOLOGY, AND THERAPEUTIC POTENTIAL IN HEPATIC AND RENAL-TRANSPLANTATION

DRUGS. 1993 OCT; 46 (4): 746-794

238

328

1434

1434 WOOD KJ

PERIPHERAL TOLERANCE TO ALLOANTIGEN - STRATEGIES FOR THE FUTURE

EUROPEAN JOURNAL OF IMMUNOGENETICS. 1993 OCT; 20 (5): 439-449

1435

1435 STARZL TE

FRANCE AND THE EARLY HISTORY OF ORGAN-TRANSPLANTATION

PERSPECTIVES IN BIOLOGY AND MEDICINE. 1993 FAL; 37 (1): 35-47

1436

1436 ABUELMAGD KM, MALINCHOC M, DICKSON ER, FUNG JJ, MURTAUGH PA, et al.

EFFICACY OF HEPATIC TRANSPLANTATION IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS

SURGERY GYNECOLOGY & OBSTETRICS. 1993 OCT; 177 (4): 335-344

1437

1437 MCDIARMID SV, COLONNA JO, SHAKED A, AMENT ME, BUSUTTIL RW

A COMPARISON OF RENAL-FUNCTION IN CYCLOSPORINE-TREATED AND FK-506-TREATED PATIENTS AFTER PRIMARY ORTHOTOPIC LIVER-TRANSPLANTATION

TRANSPLANTATION. 1993 OCT; 56 (4): 847-853

1438

1438 TABASCOMINGUILLAN J, MIELES L, CARROLL P, GAVALER J, VANTHIEL DH, et al.

INSULIN REQUIREMENTS AFTER LIVER-TRANSPLANTATION AND FK-506 IMMUNOSUPPRESSION

TRANSPLANTATION. 1993 OCT; 56 (4): 862-867

1439

1439 WREN SM, WANG SC, THAI NL, CONRAD B, HOFFMAN RA, et al.

EVIDENCE FOR EARLY TH2 T-CELL PREDOMINANCE IN XENOREACTIVITY

TRANSPLANTATION. 1993 OCT; 56 (4): 905-911

1440

1440 SCHLITT HJ, KANEHIRO H, RADDATZ G, STEINHOFF G, RICHTER N, et al.

PERSISTENCE OF DONOR LYMPHOCYTES IN LIVER ALLOGRAFT RECIPIENTS

TRANSPLANTATION. 1993 OCT; 56 (4): 1001-1007

Date / Author / Journal

LCS

GCS

LCR

1441

1441 KAMADA N, GOTO S, KOBAYASHI E, ENOSAWA S, DELRIVIERE L, et al.

RELEASE OF SOLUBLE MHC CLASS-I ANTIGENS BEFORE AND AFTER ORTHOTOPIC LIVER RETRANSPLANTATION IN THE RAT

TRANSPLANTATION PROCEEDINGS. 1993 OCT; 25 (5): 2857-2857

1442

1442 KAMADA N, KOBAYASHI E, DELRIVIERE L, GOTO S, LORD R, et al.

MIGRATION OF CELLS ENCODED BY DONOR-TYPE MHC CLASS-I ANTIGENS AFTER LIVER-TRANSPLANTATION IN THE RAT

TRANSPLANTATION PROCEEDINGS. 1993 OCT; 25 (5): 2858-2858

1443

1443 BUTTEMEYER R, JONES NF, VOGT P, STEINAU HU

CURRENT STATUS OF EXPERIMENTAL ALLOGENIC LIMB TRANSPLANTATION

CHIRURG. 1993 NOV; 64 (11): 907-912

1444

1444 WALLEMACQ PE, REDING R

FK506 (TACROLIMUS), A NOVEL IMMUNOSUPPRESSANT IN ORGAN-TRANSPLANTATION - CLINICAL, BIOMEDICAL, AND ANALYTICAL ASPECTS

CLINICAL CHEMISTRY. 1993 NOV; 39 (11): 2219-2228

101

1445

1445 LEMSTER B, WOO J, THOMSON AW

BLOOD-LYMPHOCYTES OF AUTOIMMUNE-DISEASE PATIENTS RECEIVING FK506 EXHIBIT NORMAL EX-VIVO CYTOKINE GENE- EXPRESSION AND PROLIFERATIVE RESPONSES

IMMUNOLOGY LETTERS. 1993 NOV; 38 (3): 179-183

1446

1446 FABIAN MC, LAKEY JRT, RAJOTTE RV, KNETEMAN NM

THE EFFICACY AND TOXICITY OF RAPAMYCIN IN MURINE ISLET TRANSPLANTATION - IN-VITRO AND IN-VIVO STUDIES

TRANSPLANTATION. 1993 NOV; 56 (5): 1137-1142

1447

1447 WOODLE ES, PHELAN DL, SAFFITZ JE, MOHANAKUMAR T, SHENOY S, et al.

FK506 - REVERSAL OF HUMORALLY MEDIATED CARDIAC ALLOGRAFT-REJECTION IN THE PRESENCE OF PREFORMED ANTICLASS-I ANTIBODY

TRANSPLANTATION. 1993 NOV; 56 (5): 1271-1275

1448

1448 CLARK CLI, GROVER R, POCKLEY AG, WOOD RFM

DELAYED-START CYCLOSPORINE IMMUNOSUPPRESSION REDUCES GRAFT CELL-MIGRATION AFTER SMALL-BOWEL TRANSPLANTATION

TRANSPLANTATION. 1993 NOV; 56 (5): 1284-1286

1449

1449 LOPEZGIL JA, SAIZ MG

FK506 - AN IMMUNOSUPPRESSOR FOR THE 90S

MEDICINA CLINICA. 1993 NOV 13; 101 (16): 629-636

1450

1450 KODAMA M, HANAWA H, ZHANG S, SAEKI M, KOYAMA S, et al.

FK506-THERAPY OF EXPERIMENTAL AUTOIMMUNE MYOCARDITIS AFTER ONSET OF THE DISEASE

AMERICAN HEART JOURNAL. 1993 DEC; 126 (6): 1385-1392

Date / Author / Journal

LCS

GCS

LCR

1451

1451 HEINEKE EW, JOHNSON MB, DILLBERGER JE, ROBINSON KM

ANTIOXIDANT MDL 29,311 PREVENTS DIABETES IN NONOBESE DIABETIC AND MULTIPLE LOW-DOSE STZ-INJECTED MICE

DIABETES. 1993 DEC; 42 (12): 1721-1730

1452

1452 KRENTZ AJ, DOUSSET B, MAYER D, MCMASTER P, BUCKELS J, et al.

METABOLIC EFFECTS OF CYCLOSPORINE-A AND FK-506 IN LIVER-TRANSPLANT RECIPIENTS

DIABETES. 1993 DEC; 42 (12): 1753-1759

1453

1453 THOMSON AW, STARZL TE

NEW IMMUNOSUPPRESSIVE DRUGS - MECHANISTIC INSIGHTS AND POTENTIAL THERAPEUTIC ADVANCES

IMMUNOLOGICAL REVIEWS. 1993 DEC; 136: 71-98

1454

1454 TUFVESON G, GANNEDAHL G, JOHNSSON C, OLAUSSON M, WANDERS A, et al.

NEW IMMUNOSUPPRESSANTS - TESTING AND DEVELOPMENT IN ANIMAL-MODELS AND THE CLINIC - WITH SPECIAL REFERENCE TO DSG

IMMUNOLOGICAL REVIEWS. 1993 DEC; 136: 99-109

1455

1455 LIEBERMAN R, NELSON R

DOSE-RESPONSE AND CONCENTRATION RESPONSE RELATIONSHIPS - CLINICAL AND REGULATORY PERSPECTIVES

THERAPEUTIC DRUG MONITORING. 1993 DEC; 15 (6): 498-502

1456

1456 MATSUURA T, HARA Y, IMANISHI M, KANDA H, KURITA T

PROLONGED SURVIVAL OF RAT CARDIAC ALLOGRAFTS INDUCED BY INTRATHYMIC INJECTION OF DONOR BONE-MARROW CELLS

TRANSPLANTATION PROCEEDINGS. 1993 DEC; 25 (6): 3283-3285

1457

1457 REYES J, ZEEVI A, RAMOS H, Tzakis AG, TODO S, et al.

FREQUENT ACHIEVEMENT OF A DRUG-FREE STATE AFTER ORTHOTOPIC LIVER- TRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1993 DEC; 25 (6): 3315-3319

1458

1458 DEMETRIS AJ, MURASE N, FUJISAKI S, FUNG JJ, RAO AS, et al.

HEMATOLYMPHOID CELL TRAFFICKING, MICROCHIMERISM, AND GVH REACTIONS AFTER LIVER, BONE-MARROW, AND HEART-TRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1993 DEC; 25 (6): 3337-3344

120

1459

1459 BUSCH MP, LEE TH, DONEGAN E, PALLAVICINI M

USE OF AN INBRED MOUSE MODEL SYSTEM FOR STUDIES OF ALLOGENEIC TRANSFUSION-INDUCED IMMUNOSUPPRESSION

BLOOD. 1993 DEC 1; 82 (11): 3509-3510

1994

1460

1460 Tzakis AG, TODO S, STARZL TE

INTESTINAL TRANSPLANTATION

ANNUAL REVIEW OF MEDICINE. 1994; 45: 79-91

Date / Author / Journal

LCS

GCS

LCR

1461

1461 YOUNG W, KUMEKICK J, CONSTANTINI S

GLUCOCORTICOID THERAPY OF SPINAL-CORD INJURY

HORMONAL RESTRUCTURING OF THE ADULT BRAIN. 1994; 743: 241-265

245

1462

1462 WILLIAMS LA, EGNER W, HART DNJ

ISOLATION AND FUNCTION OF HUMAN DENDRITIC CELLS

INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 153. 1994; 153: 41-103

228

1463

1463 LEE RS, AUCHINCLOSS H

MECHANISMS OF TOLERANCE TO ALLOGRAFTS

MECHANISMS OF IMMUNE REGULATION. 1994; 58: 236-258

199

1464

1464 MOCHIZUKI M, DESMET M

USE OF IMMUNOSUPPRESSIVE AGENTS IN OCULAR DISEASES

PROGRESS IN RETINAL AND EYE RESEARCH. 1994; 13 (2): 479-506

153

1465

1465 MATSUNAMI H, TADA A, MAKUUCHI M, LYNCH SV, STRONG RW

NEW TECHNIQUE FOR MEASURING TACROLIMUS CONCENTRATIONS IN BLOOD

AMERICAN JOURNAL OF HOSPITAL PHARMACY. 1994 JAN; 51 (1): 123-123

1466

1466 GORCZYNSKI RM

ADOPTIVE TRANSFER OF UNRESPONSIVENESS TO ALLOGENEIC SKIN-GRAFTS WITH HEPATIC GAMMA-DELTA(+) T-CELLS

IMMUNOLOGY. 1994 JAN; 81 (1): 27-35

1467

1467 DUNCAN JI

DIFFERENTIAL INHIBITION OF CUTANEOUS T-CELL-MEDIATED REACTIONS AND EPIDERMAL-CELL PROLIFERATION BY CYCLOSPORINE-A, FK-506, AND RAPAMYCIN

JOURNAL OF INVESTIGATIVE DERMATOLOGY. 1994 JAN; 102 (1): 84-88

1468

1468 DUMONT FJ, KASTNER C, IACOVONE F, FISCHER PA

QUANTITATIVE AND TEMPORAL ANALYSIS OF THE CELLULAR INTERACTION OF FK-506 AND RAPAMYCIN IN T-LYMPHOCYTES

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 1994 JAN; 268 (1): 32-41

1469

1469 JINDAL RM, TEPPER MA, SOLTYS K, CHO SI

DEOXYSPERGUALIN - A NOVEL IMMUNOSUPPRESSANT

MOUNT SINAI JOURNAL OF MEDICINE. 1994 JAN; 61 (1): 51-56

1470

1470 REDING R, WALLEMACQ PE, LAMY ME, RAHIER J, SEMPOUX C, et al.

CONVERSION FROM CYCLOSPORINE TO FK506 FOR SALVAGE OF IMMUNOCOMPROMISED PEDIATRIC LIVER ALLOGRAFTS - EFFICACY, TOXICITY, AND DOSE REGIMEN IN 23 CHILDREN

TRANSPLANTATION. 1994 JAN; 57 (1): 93-100

Date / Author / Journal

LCS

GCS

LCR

1471

1471 MANEZ R, KUSNE S, LINDEN P, GONZALEZPINTO I, BONET H, et al.

TEMPORARY WITHDRAWAL, OF IMMUNOSUPPRESSION FOR LIFE-THREATENING INFECTIONS AFTER LIVER-TRANSPLANTATION

TRANSPLANTATION. 1994 JAN; 57 (1): 149-151

1472

1472 CANTAROVICH D, LEMAUFF B, HOURMANT M, DANTAL J, BAATARD R, et al.

PREVENTION OF ACUTE REJECTION EPISODES WITH AN ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL-ANTIBODY .1. RESULTS AFTER COMBINED PANCREAS AND KIDNEY-TRANSPLANTATION

TRANSPLANTATION. 1994 JAN; 57 (2): 198-203

1473

1473 RUBOCKI RJ, LANGNAS AN, SHEPHERD S, DEGENHARDT JA, CATTRAL MS, et al.

THE ORIGIN OF LYMPHOCYTES IN DONOR-DERIVED LYMPH-NODES FOLLOWING COMBINED LIVER AND SMALL-BOWEL TRANSPLANTATION

TRANSPLANTATION. 1994 JAN; 57 (2): 303-306

1474

1474 CALNE R, DAVIES H

ORGAN GRAFT TOLERANCE - THE LIVER EFFECT

LANCET. 1994 JAN 8; 343 (8889): 67-68

1475

1475 BRONSTHER O, FUNG JJ, IZAKIS A, VanThiel DH, STARZL TE

PRIORITIZATION AND ORGAN DISTRIBUTION FOR LIVER-TRANSPLANTATION

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 1994 JAN 12; 271 (2): 140-143

1476

1476 ROLLES K, BURROUGHS AK, DAVIDSON BR, KARATAPANIS S, PRENTICE HG, et al.

DONOR-SPECIFIC BONE-MARROW INFUSION AFTER ORTHOTOPIC LIVER-TRANSPLANTATION

LANCET. 1994 JAN 29; 343 (8892): 263-265

1477

1477 CARTON EG, PLEVAK DJ, KRANNER PW, RETTKE SR, GEIGER HJ, et al.

PERIOPERATIVE CARE OF THE LIVER-TRANSPLANT PATIENT .2.

ANESTHESIA AND ANALGESIA. 1994 FEB; 78 (2): 382-399

151

1478

1478 YAMAMOTO S, JIANG H, KATO R

STIMULATION OF HAIR-GROWTH BY TOPICAL APPLICATION OF FK506, A POTENT IMMUNOSUPPRESSIVE AGENT

JOURNAL OF INVESTIGATIVE DERMATOLOGY. 1994 FEB; 102 (2): 160-164

1479

1479 MARTIN MF

NEPHROTOXIC EFFECTS OF IMMUNOSUPPRESSION

MAYO CLINIC PROCEEDINGS. 1994 FEB; 69 (2): 191-192

1480

1480 COOPER MH, GREGORY SH, STARZL TE, WING EJ

RAPAMYCIN BUT NOT FK506 INHIBITS THE PROLIFERATION OF MONONUCLEAR PHAGOCYTES INDUCED BY COLONY-STIMULATING FACTORS

TRANSPLANTATION. 1994 FEB 15; 57 (3): 433-439

Date / Author / Journal

LCS

GCS

LCR

1481

1481 ANDOH TF, BURDMANN EA, LINDSLEY J, HOUGHTON DC, BENNETT WM

ENHANCEMENT OF FK506 NEPHROTOXICITY BY SODIUM DEPLETION IN AN EXPERIMENTAL RAT MODEL

TRANSPLANTATION. 1994 FEB 27; 57 (4): 483-489

1482

1482 BACKMAN L, NICAR M, LEVY M, DISTANT D, EISENSTEIN C, et al.

FK506 TROUGH LEVELS IN WHOLE-BLOOD AND PLASMA IN LIVER-TRANSPLANT RECIPIENTS - CORRELATION WITH CLINICAL EVENTS AND SIDE-EFFECTS

TRANSPLANTATION. 1994 FEB 27; 57 (4): 519-525

1483

1483 NIKAEIN A, COLLINS RH, KLINTMALM G, POOLE T, FAY JW, et al.

IMMUNOLOGICAL MONITORING OF GRAFT-VERSUS-HOST DISEASE FOLLOWING ORTHOTOPIC LIVER-TRANSPLANTATION

TRANSPLANTATION. 1994 FEB 27; 57 (4): 637-640

1484

1484 LEE MS, WOGENSEN L, SHIZURU J, OLDSTONE MBA, SARVETNICK N

PANCREATIC-ISLET PRODUCTION OF MURINE INTERLEUKIN-10 DOES NOT INHIBIT IMMUNE-MEDIATED TISSUE DESTRUCTION

JOURNAL OF CLINICAL INVESTIGATION. 1994 MAR; 93 (3): 1332-1338

110

1485

1485 CHARPENTIER B, ALARD P, HIESSE C, LANTZ O

INDUCTION OF PERIPHERAL T-CELL TOLERANCE AND ALLO/XENOIMMUNITY

PATHOLOGIE BIOLOGIE. 1994 MAR; 42 (3): 237-240

1486

1486 RYDER SD, WILLIAMS R

LIVER-DISEASE

POSTGRADUATE MEDICAL JOURNAL. 1994 MAR; 70 (821): 162-184

267

1487

1487 BENDAHAN J, TYLER M, LOTZ Z, MCLEOD H, ENGELBRECHT GHC, et al.

THE EFFECT OF ADMINISTRATION OF FK506 ON DELAYED REGENERATION IN FLUSHED PARTIALLY HEPATECTOMIZED LIVERS

TRANSPLANTATION. 1994 MAR 15; 57 (5): 655-658

1488

1488 HIGH KP, JOINER KA, HANDSCHUMACHER RE

ISOLATION, CDNA SEQUENCES, AND BIOCHEMICAL-CHARACTERIZATION OF THE MAJOR CYCLOSPORINE-BINDING PROTEINS OF TOXOPLASMA-GONDII

JOURNAL OF BIOLOGICAL CHEMISTRY. 1994 MAR 25; 269 (12): 9105-9112

1489

1489 SHARMA UK, JHA V, GUPTA KL, JOSHI K, SAKHUJA V

DE-NOVO DIABETIC GLOMERULOSCLEROSIS IN A RENAL-ALLOGRAFT RECIPIENT

AMERICAN JOURNAL OF KIDNEY DISEASES. 1994 APR; 23 (4): 597-599

1490

1490 WIJDICKS EFM, WIESNER RH, DAHLKE LJ, KROM RAF

FK506-INDUCED NEUROTOXICITY IN LIVER-TRANSPLANTATION

ANNALS OF NEUROLOGY. 1994 APR; 35 (4): 498-501

Date / Author / Journal

1491

TACROLIMUS, A NEW IMMUNOSUPPRESSANT - A REVIEW OF THE LITERATURE

ANNALS OF PHARMACOTHERAPY. 1994 APR; 28 (4): 501-511

1492

1492 QIAN SW, DEMETRIS AJ, MURASE N, RAO AS, FUNG JJ, et al.

MURINE LIVER ALLOGRAFT TRANSPLANTATION - TOLERANCE AND DONOR CELL CHIMERISM

HEPATOLOGY. 1994 APR; 19 (4): 916-924

135

280

1493

1493 SANDBORN WJ, HAY JE, PORAYKO MK, GORES GJ, STEERS JL, et al.

CYCLOSPORINE WITHDRAWAL FOR NEPHROTOXICITY IN LIVER-TRANSPLANT RECIPIENTS DOES NOT RESULT IN SUSTAINED IMPROVEMENT IN KIDNEY-FUNCTION AND CAUSES CELLULAR AND DUCTOPENIC REJECTION

HEPATOLOGY. 1994 APR; 19 (4): 925-932

1494

1494 KUBIT V, SONMEZALPAN E, ZEEVI A, PARADIS I, DAUBER JH, et al.

MIXED ALLOGENEIC CHIMERISM IN LUNG ALLOGRAFT RECIPIENTS

HUMAN PATHOLOGY. 1994 APR; 25 (4): 408-412

1495

1495 WIGHT DGD

ASPECTS OF LIVER-TRANSPLANT PATHOLOGY WITH EMPHASIS ON REJECTION AND ITS MECHANISMS

JOURNAL OF CLINICAL PATHOLOGY. 1994 APR; 47 (4): 296-299

1496

1496 STRATTA RJ, TAYLOR RJ, BYNON JS, LOWELL JA, FRISBIE K, et al.

PATTERNS OF REJECTION AFTER COMBINED PANCREAS-KIDNEY TRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1994 APR; 26 (2): 524-525

1497

1497 CVETKOVIC M, MANN GN, ROMERO DF, LIANG XG, MA YF, et al.

THE DELETERIOUS EFFECTS OF LONG-TERM CYCLOSPORINE-A, CYCLOSPORINE-G, AND FK506 ON BONE-MINERAL METABOLISM IN-VIVO

TRANSPLANTATION. 1994 APR 27; 57 (8): 1231-1237

174

1498

1498 CATTRAL MS, LANGNAS AN, WISECARVER JL, HARPER JC, RUBOCKI RJ, et al.

SURVIVAL OF GRAFT-VERSUS-HOST DISEASE IN A LIVER-TRANSPLANT RECIPIENT

TRANSPLANTATION. 1994 APR 27; 57 (8): 1271-1274

1499

1499 BUSUTTIL RW, SHAKED A, MILLIS JM, JURIM O, COLQUHOUN SD, et al.

1,000 LIVER-TRANSPLANTS - THE LESSONS LEARNED

ANNALS OF SURGERY. 1994 MAY; 219 (5): 490-499

102

1500

1500 [Anon]

BASIC AND CLINICAL CONSIDERATIONS IN THE USE OF XENOGRAFTS

CURRENT PROBLEMS IN SURGERY. 1994 MAY; 31 (5): 396-460

236

The Kidney Transplant Papers 9 papers representing Starzl's ground breaking work in the area of kidney transplantation. And all the papers citing them from the SCI, AHCI, SSCI databases up-to-date as of May 2012	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 17722, GCS 106366, CR 136943 Collection span: 1963 - 2012
List of All Records